• Sonuç bulunamadı

Treatment approach to apnestic breathing in Arnold Chiari malformation: any role of non-invasive ventilation?

N/A
N/A
Protected

Academic year: 2021

Share "Treatment approach to apnestic breathing in Arnold Chiari malformation: any role of non-invasive ventilation?"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Tuberk Toraks 2020;68(4):463-464

Türktan M, Esquinas A.

463

Treatment approach to apnestic breathing in Arnold Chiari malformation: any role of non-invasive ventilation?

doi • 10.5578/tt.70017

Tuberk Toraks 2020;68(4):463-464

Geliş Tarihi/Received: 01.09.2020 • Kabul Ediliş Tarihi/Accepted: 20.09.2020

Mediha TÜRKTAN1(ID) Antonio ESQUINAS1(ID)

1 Department of Anesthesiology, Adana Cukurova University Faculty of Medicine, Adana, Turkey

1 Adana Çukurova Üniversitesi Tıp Fakültesi, Anesteziyoloji Anabilim Dalı, Adana, Türkiye

2 Intensive Care Unit, Hospital Morales Meseguer, Murcia, Spain

2 Morales Meseguer Hastanesi, Yoğun Bakım Ünitesi, Murcia, İspanya

EDİTÖRE MEKTUP LETTER TO THE EDITOR

Dear Editor,

We read with interest the article entitled “Treatment approach to apnestic breathing in a patient with vocal cord paralysis due to Arnold Chiari malformation and tracheostomy” by Ayas S, et al.

(1). Posterior fossa decompression is the first-line treatment of obstructive and/or central type apneas in patients with Arnold Chiari malformation. However, as the authors mentioned, it may not be success for every patients. In this context, CPAP and BIPAP modes are used as the first choice by the clinicians for non-inva- sive ventilation (NIV) therapy.

We consider that this original observation offers a key practical message; however, some key practical aspects need to take into account for a proper clinical application.

First, ventilator incompatibility and variability in patient needs are among the most important causes of NIV failure. In healthy adults, the minute volume decreases during sleep and this decrease may even more at different times of sleep. In the REM period, respira- tory frequency increases, tidal volume and minute volume decreases. Central apnea and hyperpnea attacks are common, most of the upper respiratory tract muscles are atonic or hypoton- Dr. Mediha TÜRKTAN

Adana Çukurova Üniversitesi Tıp Fakültesi, Anesteziyoloji Anabilim Dalı,

ADANA - TÜRKİYE

e-mail: mediturktan@gmail.com

Yazışma Adresi (Address for Correspondence) Cite this article as: Türktan M, Esquinas A. Treatment approach to apnestic breathing in Arnold Chiari mal- formation: any role of non-invasive ventilation? Tuberk Toraks 2020;68(4):463-464.

©Copyright 2020 by Tuberculosis and Thorax.

Available on-line at www.tuberktoraks.org.com

(2)

Tuberk Toraks 2020;68(4):463-464

Treatment approach to apnestic breathing in Arnold Chiari malformation: any role of non-invasive ventilation?

464

ic in this period. Motor neuron activity increases, there is a rapid and irregular respiration. If resistance increases in the upper airway or the airway is obstructed, patients enter a wakefulness period. For these reasons, new modes may be useful in NIV administration in obesity hypoventilation syndrome (OHS), COPD, neuromuscular diseases and chronic hypoventilation.

Second, in recent years, the most frequently used new ventilation modes are IVAPS (intelligent vol- ume-assured pressure support), AVAPS (average vol- ume assured pressure ventilation) and PAV. AVAPS is a combined mode that guarantees constant tidal vol- ume in addition to pressure support. It was primarily applied to patients with OHS who did not respond to CPAP therapy. Thus, appropriate support is provided for the new respiratory condition during sleep and position changes. It has been shown that AVAPS mode applied in OHS and COPD patients provides a greater reduction in the level of PaCO2 in a shorter time than BIPAP and CPAP (2). Significant decrease in nocturnal PaCO2 was also observed with AVAPS compared to other modes (2,3). The success rate in chronic obstructive pulmonary disease is reported as 76.4% (4). Intelligent volume-assured pressured sup- port (IVAPS) was also associated with a reduction in the maximum PaCO2 during NREM sleep as com- pared to traditional BIPAP mode (5). Another reason for the NIV failure is the leak from the mask and it has been shown that mask leaks can be prevented with AVAPS mode (6). Ayas et al. successfully applied the AVAPS mode in patient with tracheostomy without leakage (1).

Finally, there are also studies showing that there is no difference between the new NIV modes and the tra- ditional NIV modes in terms of sleep quality and patient compliance (7). New NIV strategies may be particularly useful in certain patients groups undergo-

ing mechanical ventilation at home. However, the benefits of AVAPS and IVAPS have been demostrated in some small size studies and their roles on NIV threapy have not been fully defined by the literature.

Thus, BPAP-CPAP is currently accepted standard NIV mode in central or obstructive type apnea.

More comprehensive studies are needed in this area for new NIV modes to be included in the central apnea management guideline.

REFERENCES

1. Ayas S,  Şenel GB,  Karadeniz D.  Treatment approach to apnestic breathing in a patient with vocal cord paralysis due to Arnold Chiari malformation and tracheostomy.

Tuberk Toraks 2020; 68(2): 175-83.

2. Storre JH,  Seuthe B,  Fiechter R,  Milioglou S,  Dreher M,  Sorichter S,  et al. Average volume-assured pressure support in obesity hypoventilation: A randomized cross- over trial. Chest 2006; 130(3): 815-21.

3. Claudett KHB, Claudett MB,  Wong MCS,  Martinez AN, Espinoza RS, Montalvo M, et al. Noninvasive mechan- ical ventilation with average volume assured pressure support (AVAPS) in patients with chronic obstructive pul- monary disease and hypercapnic encephalopathy. BMC Pulm Med 2013; 13: 12.

4. Çiftci F, Çiledağ A, Erol S, Öz M, Acar D, Kaya A. Evaluation of the feasibility of average volume-assured pressure sup- port ventilation in the treatment of acute hypercapnic respiratory failure associated with chronic obstructive pulmonary disease: A pilot study. J Crit Care  2017; 39:

232-7.

5. Khayat A, Medin D, Syed F, Moraes TJ, Bin-Hasan S, Narang I, et al. Intelligent volume-assured pressured sup- port (IVAPS) for the treatment of congenital central hypoventilation syndrome. Sleep Breath 2017; 21(2): 513- 9.

6. Kaya PK, Kahveci FŞ. Noninvaziv mekanik ventilasyon.

[AVAPS: Average Volume-Assured Pressure Support]. 1.

Baskı. Ankara, Akademisyen Yayınevi; 2018, 109-15.

7. Rabec C, Emeriaud G, Amadeo A, Fauroux B, Georges M.

New modes in non-invasive ventilation. Paediatr Respir Rev 2016; 18: 73-84.

Referanslar

Benzer Belgeler

7 Tip I ACM cerrahi operasyon ile doğru bir şekilde düzeltilmemiş ve intrakranial basınç artış bulguları olmayan, beklenen zor entübasyonlu hastalarda epi- dural anestezi

Knowing the fact of required sophisticated studies to evaluate the role on blood pressure, on the current background, we would like to speculate that BMP-4 antagonists might

We herein present a case of restrictive lung disease and acute hypercapnic respiratory failure due to kyphoscoliosis, which was successfully treated with non-invasive

We aimed to investigate the change in arterial lactate level in blood after PAP treatment in patients with obstructive sleep apnea (OSA) and sleep- related hypoventilation

Objective: We aimed to determine tumor marker levels in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) at the time of diagnosis, to investigate

Many reviews actually suggest that pa- tients with higher risks for postoperative respiratory failure; including the individuals who are obese or af- fected by lung diseases and

1911 yılında 165 000 lira sermayeli Osmanlı Şirketi adı altında gûya bize ait bir şirket, İşletmeyi devraldı.. Bu özel sektör, gerçekte gene İrıgilizlerin

In our study, we have found that there were also some conditions associated with CMI including syringomyelia in upper cervical region (30.3%), clivus defect and concavity